939
Views
2
CrossRef citations to date
0
Altmetric
Research Papers

The early-onset febrile reaction following vaccination and associated factors: An exploratory sub-study based on the Ebola vaccine clinical trial

, , , , , , , , , , , , , , & show all
Pages 1441-1446 | Received 11 Nov 2016, Accepted 25 Jan 2017, Published online: 31 Mar 2017

References

  • Centers for Disease Control and Prevention. 2014 Ebola outbreak in West Africa-case counts. 2015. Available at: http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html
  • Qiu X, Wong G, Fernando L, Audet J, Bello A, Strong J, Alimonti JB, Kobinger GP. mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms. Sci Transl Med 2013; 5:207ra143-207ra143; PMID:24132638; https://doi.org/10.1126/scitranslmed.3006605
  • Zhu FC, Hou LH, Li JX, Wu SP, Liu P, Zhang GR, Hu YM, Meng FY, Xu JJ, Tang R, et al. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet 2015; 385:2272-9; https://doi.org/10.1016/S0140-6736(15)60553-0
  • Huttner A, Dayer JA, Yerly S, Combescure C, Auderset F, Desmeules J, Eickmann M, Finckh A, Goncalves AR, Hooper JW, et al. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. Lancet Infectious Diseases 2015; 15:1156-66; PMID:26248510; https://doi.org/10.1016/S1473-3099(15)00154-1
  • China Food and Drug Administration. The standard guidelines for adverse reactions grading of vaccine clinical trials. http://www.sda.gov.cn/WS01/CL1036/9350_5.html. 2005.
  • Tingle AJ, Allen M, Petty RE, Kettyls GD, Chantler JK. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation. Ann Rheum Dis 1986; 45:110-4.
  • Pfister M, Kürsteiner O, Hilfiker H, Favre D, Durrer P, Ennaji A, L'Age-Stehr J, Kaufhold A, Herzog C. Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial. Am J Trop Med Hyg 2005; 72:339-46.
  • Cook IF. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 2008; 26:3551-5; PMID:18524433; https://doi.org/10.1016/j.vaccine.2008.04.054
  • Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 2010; 10:338-49; PMID:20417416; https://doi.org/10.1016/S1473-3099(10)70049-9
  • Broder K, Setse R, Pahud B, Hrncir D, Choi H, Sparks R, Williams SE, Engler RJ, Gidudu J, Baxter R, et al. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS. Vaccine 2013; 31:6107-12; PMID:24120547; https://doi.org/10.1016/j.vaccine.2013.09.066
  • Krams IA, Skrinda I, Kecko S, Moore FR, Krama T, Kaasik A, Meija L, Lietuvietis V, Rantala MJ. Body height affects the strength of immune response in young men, but not young women. Scientific Reports 2014; 4:6223; PMID:25164474; PMID:25164474; https://doi.org/10.1038/srep06223
  • Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J. 2001; 20:733-40; PMID:11734733; https://doi.org/10.1097/00006454-200108000-00004
  • Tapiainen. T, Heininger. U. Fever following immunization. EXPERT REVIEW OF VACCINES 2005; 4:419-27; https://doi.org/10.1586/14760584.4.3.419
  • Mackowiak PA. Concepts of fever. Archives of Internal Medicine 1998; 158:1870-81; PMID:9759682; https://doi.org/10.1001/archinte.158.17.1870
  • Marcy SM, Kohl KS, Dagan R, Nalin D, Blum M, Jones MC, Hansen J, Labadie J, Lee L, Martin BL, et al. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004; 22:551-6; PMID:14741143; https://doi.org/10.1016/j.vaccine.2003.09.007
  • Gonzalez FC, Villegas OO, Ramirez DE, Sanchez VG, Dominguez HO. Smart multi-level tool for remote patient monitoring based on a wireless sensor network and mobile augmented reality. Sensors 2014; 14:17212-34; PMID:25230306; https://doi.org/10.3390/s140917212
  • Fensli R, Gundersen T, Snaprud T, Hejlesen O. Clinical evaluation of a wireless ECG sensor system for arrhythmia diagnostic purposes. Med Eng Phys 2013; 35:697-703; https://doi.org/10.1016/j.medengphy.2013.03.002
  • Boano CA, Lasagni M, Romer K, Lange T. Accurate temperature measurements for medical research using body sensor networks. In: ISORCW '11 Proceedings of the 2011 14th IEEE International Symposium on Object/Component/Service-Oriented Real-Time Distributed Computing Workshops. Washington, DC: IEEE Computer Society; 2011; 189-98.
  • Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, et al. Surveillance for Safety After Immunization: Vaccine Adverse Event Reporting System (VAERS) — United States, 1991–2001. Mmwr Surveill Summ 2003; 52:1-24; PMID:12825543
  • Uhari M, Möttönen M. An open randomized controlled trial of infection prevention in child day-care centers. Pediatr Infect Dis J 1999; 18:672-7; PMID:10462334; https://doi.org/10.1097/00006454-199908000-00004
  • Fine PE, Chen RT. Confounding in Studies of Adverse Reactions to Vaccines. American Journal of Epidemiology 1992; 136:121-35; PMID:1415136
  • Virtanen M, Peltola H, Paunio M, Heinonen OP. Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics 2000; 106:E62-E; PMID:11061799; https://doi.org/10.1542/peds.106.5.e62
  • Schmitt-Grohé S, Stehr K, Cherry JD, Heininger U, Uberall MA, Laussucq S, Eckhardt T. Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group. Developments in Biological Standardization 1997; 89: 113-8.
  • Tozzi AE, Anemona A, Stefanelli P, Salmaso S, Ciofi degli Atti ML, Mastrantonio P, Giammanco A, Progetto Pertosse Study Group. Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. Pediatrics 2001; 107: 64-8; https://doi.org/10.1542/peds.107.2.e25
  • Govaert TM, Dinant GJ, Aretz K, Masurel N, Sprenger MJ, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. Bmj 1993; 307: 988-90; PMID:8241913; https://doi.org/10.1136/bmj.307.6910.988
  • Kobune F, Funatu M, Takahashi H, Fukushima M, Kawamoto A, Iizuka S, Sakata H, Yamazaki S, Arita M, Xu W, et al. Characterization of measles viruses isolated after measles vaccination. Vaccine 1995; 13:370-2; PMID:7793133; https://doi.org/10.1016/0264-410X(95)98259-D
  • Feng-Cai ZWC, Li-Hua Hou, Jing-Xin Li, Yue-Mei Hu, Fan-Yue Meng, Gui-Rong Zhang, Pei Liu, Rong Tang. A Phase 1 Clinical Trial to Evaluate the Recombinant Human Type 5 Adenovirus Vector Based Ebola Vaccine (Ad5-EBOV) in Healthy Adults. http://jscdc.cn/jgzn/zzjg/kyjyk/. 2015.
  • Chen F. Statistical methods for dependent data. In: Ying L, Fang J, Tian L, Jin H, eds. Advanced Medical Statistics. Hackensack, NJ: World Scientific; 2015; 1173-228.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.